Adage Capital Management

Adage Capital Management

Signal active

Investment Firm

Overview

Adage Capital Management is a Boston-based $8.9B Money Management firm focused on managing S&P 500 assets predominantly for Endowments and Foundations such as Harvard University, Northwestern University, Dartmouth College, the American Red Cross and the Getty Foundation. Adage and its predecessor, the Select Equity Group at the Harvard Management Company, has outperformed the S&P index in each of the last 15 years by an average of 3.5%.

The fund is run by Phill Gross, who prior to founding Adage, was a Healthcare and Retail analyst, equity research director and partner at the Harvard Management Company for 18 years..

Highlights

Founded

2001

Industry

Financial Services

Employees

11-50

Investment

122

Lead Investment

10

Exits

87

Stages

Late Stage Venture, Private Equity, Early Stage Venture

Investor Type

Government Office

Location

United States, North America

Contact Information

Social

Profile Resume

Adage Capital Management, established in 2001 and headquartered in United States, North America., specializes in Late Stage Venture, Private Equity, Early Stage Venture investments across Biotechnology, Health Care, Pharmaceutical, Medical, Venture Capital, Finance, Business Development, Photography, Angel Investment, Financial Services. The organization boasts a portfolio of 122 investments, with an average round size of $118.7M and 87 successful exits. Their recent investments include Concert Pharmaceuticals, Flagship Pioneering, Brookside Capital, Skyline Ventures, Three Arch Partners. The highest investment round they participated in was $1602.0B. Among their most notable exits are Concert Pharmaceuticals and Flagship Pioneering. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.

Employees

imagePlace Richmond Holden

Richmond Holden

Technology Investor

Investment portfolio

Adage Capital Management has made 122 investments. Their most recent investment was on Jun 14, 2024, when Disc Medicine raised $178.0M.

Adage Capital Management has made 24 diversity investments. Their most recent diversity investment was on Apr 11, 2024, when Century Therapeutics raised $60.0M.

investments

122

Diversity investments

24

Lead investments

10

Number of exits

87

Investments

122

Annouced DateOrganization NameIndustryMoney Raised
Apr 16, 2024--280.0M
Apr 18, 2024
Benitec Ltd Benitec Ltd
Biotechnology40.0M
May 03, 2024
Abeona Therapeutics Abeona Therapeutics
Biotechnology75.0M
Jun 14, 2024
Disc Medicine Disc Medicine
Biotechnology178.0M

Exits

87

Funding Timeline

Funding rounds

122

Investors

0

Funds

1

Funding Rounds

122

Adage Capital Management has raised 122 rounds. Their latest funding was raised on Jun 14, 2024 from a Post-IPO Equity - Disc Medicine round.

Annouced DateTransaction NameNumber of InvestorsMoney RaisedLead Investor
Apr 16, 2024
Post-IPO Equity - Cullinan Therapeutics Post-IPO Equity - Cullinan Therapeutics
-280.0M-
Apr 18, 2024
Post-IPO Equity - Benitec Ltd Post-IPO Equity - Benitec Ltd
-40.0M-
May 03, 2024
Post-IPO Equity - Abeona Therapeutics Post-IPO Equity - Abeona Therapeutics
-75.0M-
Jun 14, 2024
Post-IPO Equity - Disc Medicine Post-IPO Equity - Disc Medicine
-178.0M-

Investors

0

There is no funding round available on this profile

Fund raised

2

Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.

Annouced DateFund NameMoney Raised
May 10, 2013
fund image OTPPLESS
1.0M
May 11, 2013
fund image OTPPLESS
1.0M

Invest in industries

Recent Activity

There is no recent news or activity for this profile.